Schroder Investment Management Group Amgen Inc Transaction History

Schroder Investment Management Group

$87.8 Billion
Q2 2024

A detailed history of Schroder Investment Management Group transactions in Amgen Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 595,943 shares of AMGN stock, worth $188 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

595,943

Previous 519,259 14.77%

Holding current value

$188 Million

Previous $148 Million 26.12%

% of portfolio

0.21%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $20.1 Million - $24.5 Million	76,684 Added 14.77%	595,943 $186 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $8.28 Million - $10 Million	30,808 Added 6.31%	519,259 $148 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $20.4 Million - $23.1 Million	79,919 Added 19.56%	488,451 $141 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $15.5 Million - $19.2 Million	-70,862 Reduced 14.78%	408,532 $110 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $47.4 Million - $56 Million	-221,090 Reduced 31.56%	479,394 $106 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $1.03 Million - $1.26 Million	4,570 Added 0.66%	700,484 $169 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $19.9 Million - $25.2 Million	-86,689 Reduced 11.08%	695,914 $183 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $2.54 Million - $2.87 Million	11,318 Added 1.47%	782,603 $176 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $2.84 Million - $3.16 Million	-12,317 Reduced 1.57%	771,285 $189 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $48.2 Million - $53.3 Million	-219,599 Reduced 21.89%	783,602 $190 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $9.2 Million - $10.5 Million	46,252 Added 4.83%	1,003,201 $226 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $19.2 Million - $22.4 Million	-90,266 Reduced 8.62%	956,949 $203 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $45,781 - $50,791	-196 Reduced 0.02%	1,047,215 $255 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $19.7 Million - $23 Million	-88,833 Reduced 7.82%	1,047,411 $261 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $41 Million - $48.8 Million	-189,455 Reduced 14.29%	1,136,244 $261 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $18 Million - $20 Million	-76,636 Reduced 5.46%	1,325,699 $325 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $12.9 Million - $15.8 Million	65,169 Added 4.87%	1,402,335 $331 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $20.2 Million - $26.8 Million	-110,715 Reduced 7.65%	1,337,166 $283 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $17.3 Million - $22.3 Million	-91,634 Reduced 5.95%	1,447,881 $349 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $2.95 Million - $3.53 Million	-16,927 Reduced 1.09%	1,539,515 $300 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $3.44 Million - $4.03 Million	-20,624 Reduced 1.31%	1,556,442 $287 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $19.7 Million - $22.3 Million	109,168 Added 7.44%	1,577,066 $300 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $9.46 Million - $11 Million	53,044 Added 3.75%	1,467,898 $286 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $29.6 Million - $33.3 Million	-159,592 Reduced 10.14%	1,414,854 $293 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $33.9 Million - $38.1 Million	-204,115 Reduced 11.48%	1,574,446 $289 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $133 Million - $156 Million	-786,142 Reduced 30.65%	1,778,561 $303 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $18.1 Million - $20.2 Million	107,149 Added 4.36%	2,564,703 $446 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $411 Million - $469 Million	2,457,554	2,457,554 $456 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Amgen Inc Transaction History